JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB57461

Anti-ARID1B antibody [2D2]

5

(2 Reviews)

|

(32 Publications)

Anti-ARID1B antibody [2D2] (ab57461) is a mouse monoclonal antibody detecting ARID1B in Western Blot, Flow Cytometry, IHC-P, ICC/IF. Suitable for Human.

- KO validated for confirmed specificity
- Over 20 publications
- Trusted since 2007

View Alternative Names

BAF250B, DAN15, KIAA1235, OSA2, ARID1B, AT-rich interactive domain-containing protein 1B, ARID domain-containing protein 1B, BRG1-associated factor 250b, BRG1-binding protein hELD/OSA1, Osa homolog 2, p250R, hOsa2

7 Images
Western blot - Anti-ARID1B antibody [2D2] (AB57461)
  • WB

Lab

Western blot - Anti-ARID1B antibody [2D2] (AB57461)

Western blot : Mouse Monoclonal[2D2] to ARID1B ab57461 staining at 1/1000 dilution, shown in green; Rabbit anti alpha Tubulin (ab52866) loading control staining at 1/20,000 dilution, shown in magenta. A band was observed at 200 kDa in Wild-type HCT 116 Nuclear cell lysates with no signal observed at this size in ARID1B knockout HCT 116 Nuclear cell line. To generate this image, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 5pc Milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4°C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Mouse 800CW & Goat anti-Rabbit 680RD at 1/20,000 dilution.

All lanes:

Western blot - Anti-ARID1B antibody [2D2] (ab57461) at 1/1000 dilution

Lane 1:

Wild-type HCT 116 Nuclear at 20 µg

Lane 2:

Western blot - Human ARID1B knockout HCT116 cell line (<a href='/en-us/products/cell-lines/human-arid1b-knockout-hct116-cell-line-ab287219'>ab287219</a>) at 20 µg

Lane 3:

RKO at 20 µg

Lane 4:

PC-3 Membrane at 20 µg

Secondary

All lanes:

Goat anti-Mouse 800CW & Goat anti-Rabbit 680RD at 1/20000 dilution

Predicted band size: 244 kDa

Observed band size: 200 kDa

false

Immunocytochemistry/ Immunofluorescence - Anti-ARID1B antibody [2D2] (AB57461)
  • ICC/IF

Supplier Data

Immunocytochemistry/ Immunofluorescence - Anti-ARID1B antibody [2D2] (AB57461)

Immunocytochemistry/Immunofluorescence analysis of HeLa (human cervix adenocarcinoma epithelial cell) cells labelling ARID1B (Green) with ab57461 at 10 µg/mL concentration.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ARID1B antibody [2D2] (AB57461)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ARID1B antibody [2D2] (AB57461)

Immunoperoxidase analysis of formalin-fixed paraffin-embedded human kidney tissue labelling ARID1B with ab57461 at 3 µg/mL concentration.

Immunoprecipitation - Anti-ARID1B antibody [2D2] (AB57461)
  • IP

Supplier Data

Immunoprecipitation - Anti-ARID1B antibody [2D2] (AB57461)

Immunoprecipitation of ARID1B in HCT 116 cells. Lysates were prepared and immunoprecipitation was performed using 2 μg of ab57461 pre-coupled to Protein A beads. Samples were then washed and processed for western blot.

This data was provided by YCharOS Inc., an open science company with the mission of characterizing commercially available antibody reagents for all human proteins. Abcam and YCharOS are working together to help address the reproducibility crisis by enabling the life science community to better evaluate commercially available antibodies.

All lanes:

Immunoprecipitation - Anti-ARID1B antibody [2D2] (ab57461) at 2 µg

All lanes:

HCT 116 cell lysates

Predicted band size: 244 kDa

false

Western blot - Anti-ARID1B antibody [2D2] (AB57461)
  • WB

Supplier Data

Western blot - Anti-ARID1B antibody [2D2] (AB57461)

ab57461 was shown to react with ARID1B in wild-type HCT 116 cells in Western blot with loss of signal observed in ARID1B knockout cell line ab287219. Wild-type HCT 116 and ARID1B knockout cell lysates were subjected to SDS-PAGE. Membranes were blocked in 5% milk in TBST for 1 hr before incubation with ab57461 overnight at 4°C at a 1/1000 dilution. Blots were incubated with secondary antibodies at 0.2 µg/mL before imaging.

This data was provided by YCharOS Inc., an open science company with the mission of characterizing commercially available antibody reagents for all human proteins. Abcam and YCharOS are working together to help address the reproducibility crisis by enabling the life science community to better evaluate commercially available antibodies.

All lanes:

Western blot - Anti-ARID1B antibody [2D2] (ab57461) at 1/1000 dilution

Lane 1:

Wild-type HCT 116 lysate at 30 µg

Lane 2:

ARID1B knock-out HCT 116 lysate at 30 µg

Lane 2:

Western blot - Human ARID1B knockout HCT116 cell line (<a href='/en-us/products/cell-lines/human-arid1b-knockout-hct116-cell-line-ab287219'>ab287219</a>)

Observed band size: 244 kDa

false

Western blot - Anti-ARID1B antibody [2D2] (AB57461)
  • WB

Supplier Data

Western blot - Anti-ARID1B antibody [2D2] (AB57461)

Blocking and diluting buffer and concentration : 5% non-fat milk/PBST (0.2%).

All lanes:

Western blot - Anti-ARID1B antibody [2D2] (ab57461) at 5 µg/mL

All lanes:

Western blot - Anti-ARID1B antibody [2D2] (ab57461) at 50 µg

Secondary

All lanes:

Goat Anti-Mouse IgG (H&L)-HRP Conjugate at 1/5000 dilution

Predicted band size: 236 kDa

false

Sandwich ELISA - Anti-ARID1B antibody [2D2] (AB57461)
  • sELISA

Supplier Data

Sandwich ELISA - Anti-ARID1B antibody [2D2] (AB57461)

Sandwich ELSIA standard curve using ab57461 as a capture antibody. Detection limit for recombinant GST tagged ARID1B is 0.03 ng/mL.

Key facts

Host species

Mouse

Clonality

Monoclonal

Clone number

2D2

Isotype

IgG2b

Light chain type

kappa

Carrier free

Yes

Reacts with

Human

Applications

WB, Flow Cyt, ICC/IF, IHC-P, IP

applications

Immunogen

Recombinant Fragment Protein within Human ARID1B aa 1350 to C-terminus. The exact immunogen used to generate this antibody is proprietary information.

Q8NFD5

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "FlowCyt" : {"fullname" : "Flow Cytometry", "shortname":"Flow Cyt"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "FlowCyt-species-checked": "testedAndGuaranteed", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "<p><a href='/en-us/products/primary-antibodies/mouse-igg2b-kappa-monoclonal-7e10g10-isotype-control-ab170192'>ab170192</a> - Mouse monoclonal IgG2b, is suitable for use as an isotype control with this antibody.</p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>", "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "2 µg", "IP-species-notes": "<p></p>" } } }

Product details

What is this antibody validated in?
Anti-ARID1B antibody [2D2] (ab57461) is a mouse monoclonal antibody and is validated for use in Western Blot (WB), Flow Cytometry (Flow Cyt), Immunohistochemistry (IHC-P), Immunocytochemistry/immunofluorescence (ICC/IF) in Human samples.

What is the molecular weight of ARID1B?
Anti-ARID1B [2D2] (ab57461) specifically detects a band for ARID1B (UniProt: Q8NFD5) at a molecular weight of 236kDa.

Trusted by the scientific community
Anti-ARID1B [2D2] (ab57461) was first used in a scientific publication in 2007 and has been cited over 20 times in peer-reviewed journals.

Specificity confirmed
The specificity of Anti-ARID1B antibody [2D2] (ab57461) has been confirmed by Western blot testing in ARID1B Knockout HCT 116 cells.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.4 Constituents: PBS
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

ARID1B also known as BAF250b is a component of the SWI/SNF chromatin remodeling complex. This protein has a mass of approximately 250 kDa. ARID1B interacts with DNA to regulate gene expression by modifying the chromatin structure making it more accessible for transcription machinery. It is expressed in various tissues including the brain heart and skeletal muscle suggesting a role in diverse physiological processes.
Biological function summary

The protein participates in the regulation of transcription by altering the chromatin architecture. As part of the SWI/SNF complex ARID1B works alongside other proteins to control which parts of the genome are accessible for transcription. Its activity influences numerous cellular events like cell differentiation and proliferation. The SWI/SNF complex plays a significant role in embryonic development and tumor suppression.

Pathways

ARID1B affects several critical biological processes such as Wnt signaling and cell cycle regulation. The protein interacts with beta-catenin in the Wnt pathway affecting gene expression and cell fate decisions. Additionally ARID1B modulates the cell cycle directly by influencing the expression of cyclins and cyclin-dependent kinases proteins essential for cell cycle progression.

Mutations in the ARID1B gene have associations with neurodevelopmental conditions like Coffin-Siris syndrome and intellectual disabilities. The protein's malfunction can disrupt normal brain development through pathways involving CREBBP a known coactivator in transcription. Additionally ARID1B alterations appear in certain cancers often resulting in abnormal proliferation and differentiation in affected cells highlighting the importance of its regulatory functions in maintaining cellular health.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Involved in transcriptional activation and repression of select genes by chromatin remodeling (alteration of DNA-nucleosome topology). Component of SWI/SNF chromatin remodeling complexes that carry out key enzymatic activities, changing chromatin structure by altering DNA-histone contacts within a nucleosome in an ATP-dependent manner. Belongs to the neural progenitors-specific chromatin remodeling complex (npBAF complex) and the neuron-specific chromatin remodeling complex (nBAF complex). During neural development a switch from a stem/progenitor to a postmitotic chromatin remodeling mechanism occurs as neurons exit the cell cycle and become committed to their adult state. The transition from proliferating neural stem/progenitor cells to postmitotic neurons requires a switch in subunit composition of the npBAF and nBAF complexes. As neural progenitors exit mitosis and differentiate into neurons, npBAF complexes which contain ACTL6A/BAF53A and PHF10/BAF45A, are exchanged for homologous alternative ACTL6B/BAF53B and DPF1/BAF45B or DPF3/BAF45C subunits in neuron-specific complexes (nBAF). The npBAF complex is essential for the self-renewal/proliferative capacity of the multipotent neural stem cells. The nBAF complex along with CREST plays a role regulating the activity of genes essential for dendrite growth (By similarity). Binds DNA non-specifically (PubMed : 14982958, PubMed : 15170388).
See full target information ARID1B

Publications (32)

Recent publications for all applications. Explore the full list and refine your search

Biomedical reports 23:119 PubMed40463397

2025

Relationship between the protein expression of ARID1A, ARID1B and ARID2 with the clinicopathological characteristics of colorectal cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Wariya Mongkolwat,Phattarapon Sonthi,Keerakarn Somsuan,Siripat Aluksanasuwan,Ratirath Samol,Natthiya Sakulsak,Sasithorn Wanna-Udom

Nature communications 15:4614 PubMed38816354

2024

ARID1B maintains mesenchymal stem cell quiescence via inhibition of BCL11B-mediated non-canonical Activin signaling.

Applications

Unspecified application

Species

Unspecified reactive species

Mingyi Zhang,Tingwei Guo,Fei Pei,Jifan Feng,Junjun Jing,Jian Xu,Takahiko Yamada,Thach-Vu Ho,Jiahui Du,Prerna Sehgal,Yang Chai

Cell 186:4936-4955.e26 PubMed37788668

2023

A disordered region controls cBAF activity via condensation and partner recruitment.

Applications

Unspecified application

Species

Unspecified reactive species

Ajinkya Patil,Amy R Strom,Joao A Paulo,Clayton K Collings,Kiersten M Ruff,Min Kyung Shinn,Akshay Sankar,Kasey S Cervantes,Tobias Wauer,Jessica D St Laurent,Grace Xu,Lindsay A Becker,Steven P Gygi,Rohit V Pappu,Clifford P Brangwynne,Cigall Kadoch

Frontiers in oncology 13:1099550 PubMed36793594

2023

MS0621, a novel small-molecule modulator of Ewing sarcoma chromatin accessibility, interacts with an RNA-associated macromolecular complex and influences RNA splicing.

Applications

Unspecified application

Species

Unspecified reactive species

Tamara Vital,Aminah Wali,Kyle V Butler,Yan Xiong,Joseph P Foster,Shelsa S Marcel,Andrew W McFadden,Valerie U Nguyen,Benton M Bailey,Kelsey N Lamb,Lindsey I James,Stephen V Frye,Amber L Mosely,Jian Jin,Samantha G Pattenden,Ian J Davis

EMBO reports 24:e55345 PubMed36354291

2022

Paraspeckles interact with SWI/SNF subunit ARID1B to regulate transcription and splicing.

Applications

Unspecified application

Species

Unspecified reactive species

Divya Reddy,Saikat Bhattacharya,Michaella Levy,Ying Zhang,Madelaine Gogol,Hua Li,Laurence Florens,Jerry L Workman

Nature communications 13:5051 PubMed36030255

2022

Early postnatal serotonin modulation prevents adult-stage deficits in Arid1b-deficient mice through synaptic transcriptional reprogramming.

Applications

Unspecified application

Species

Unspecified reactive species

Hyosang Kim,Doyoun Kim,Yisul Cho,Kyungdeok Kim,Junyeop Daniel Roh,Yangsik Kim,Esther Yang,Seong Soon Kim,Sunjoo Ahn,Hyun Kim,Hyojin Kang,Yongchul Bae,Eunjoon Kim

Cancer cell 40:768-786.e7 PubMed35750052

2022

Genome-wide CRISPR screens of T cell exhaustion identify chromatin remodeling factors that limit T cell persistence.

Applications

Unspecified application

Species

Unspecified reactive species

Julia A Belk,Winnie Yao,Nghi Ly,Katherine A Freitas,Yan-Ting Chen,Quanming Shi,Alfredo M Valencia,Eric Shifrut,Nupura Kale,Kathryn E Yost,Connor V Duffy,Bence Daniel,Madeline A Hwee,Zhuang Miao,Alan Ashworth,Crystal L Mackall,Alexander Marson,Julia Carnevale,Santosh A Vardhana,Ansuman T Satpathy

Nature communications 12:6469 PubMed34753942

2021

Inability to switch from ARID1A-BAF to ARID1B-BAF impairs exit from pluripotency and commitment towards neural crest formation in ARID1B-related neurodevelopmental disorders.

Applications

Unspecified application

Species

Unspecified reactive species

Luca Pagliaroli,Patrizia Porazzi,Alyxandra T Curtis,Chiara Scopa,Harald M M Mikkers,Christian Freund,Lucia Daxinger,Sandra Deliard,Sarah A Welsh,Sarah Offley,Connor A Ott,Bruno Calabretta,Samantha A Brugmann,Gijs W E Santen,Marco Trizzino

Cancer discovery 11:2620-2637 PubMed34078620

2021

A Role for SMARCB1 in Synovial Sarcomagenesis Reveals That SS18-SSX Induces Canonical BAF Destruction.

Applications

Unspecified application

Species

Unspecified reactive species

Jinxiu Li,Timothy S Mulvihill,Li Li,Jared J Barrott,Mary L Nelson,Lena Wagner,Ian C Lock,Amir Pozner,Sydney Lynn Lambert,Benjamin B Ozenberger,Michael B Ward,Allie H Grossmann,Ting Liu,Ana Banito,Bradley R Cairns,Kevin B Jones

Cell reports 35:109127 PubMed34010636

2021

Nuclear isoform of FGF13 regulates post-natal neurogenesis in the hippocampus through an epigenomic mechanism.

Applications

Unspecified application

Species

Unspecified reactive species

Qiao-Qiao Yang,Ying-Qi Zhai,Hai-Fang Wang,Yu-Chen Cai,Xin-Yue Ma,Yan-Qing Yin,Yan-Dong Li,Guo-Min Zhou,Xu Zhang,Gang Hu,Jia-Wei Zhou
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com